Alliant’s 2025 Global Health Review
The 2025 Global Health Review published by Alliant’s Global Practice, with the support of the Asinta Partnership, gives multinational employers insights and strategies to address employee benefits and well-being challenges in a rapidly shifting landscape. The report extensively analyses the considerable traction GLP1s (semaglutide and tirzepatide) have gained in treating obesity and what employers can do to create a unified, conservative global approach for coverage of GLP1s as they begin to show promise in treating several other diseases.
A strategic framework for proactive global engagement is also a core component of the report. It offers a path towards ‘intentional innovation’ to go beyond superficial cost-cutting measures that provide temporary respite, such as increasing co-pays and deductibles, and instead focus on initiatives that serve the dual strategic objectives of long-term sustainability and employee resilience.
In addition, Alliant’s 2025 Global Health Review provides in-depth coverage on:
- Global highlights of special significance in medical insurance programs (Brazil, UK, India)
- Strategies and solutions multinational employers can adopt to address the global mental health crisis effectively
- Medical trend analysis (the predicted change in health plans’ per capita claims costs) for the Americas, APAC, and Europe
If you are a US employer who wants the resources and insights needed to craft sustainable and impactful benefit programs, please get in touch with Asinta, and we will put you in touch with the global employee benefits consulting experts at Alliant.